Skip to main content
ITACONIX PLC logo

ITACONIX PLC — Investor Relations & Filings

Ticker · ITX ISIN · GB00BPK3YZ68 LEI · 213800OKA3GOCK2ZA496 IL Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2017-09-18 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL ITX

About ITACONIX PLC

https://www.itaconix.com

Itaconix PLC is an innovator in sustainable, plant-based polymers derived from itaconic acid. The company develops, manufactures, and markets specialty ingredients used to decarbonize everyday consumer products. Its products serve as high-performance, eco-friendly alternatives to conventional fossil-based compounds in the home care, personal care, and beauty markets. Key offerings include performance additives that provide benefits such as scale inhibition (Itaconix® TSI® 322) and permanent odor neutralization (Itaconix® ONZ™ 400). The company also provides turnkey formulated solutions for cleaning and hygiene products, as well as specialty itaconate monomers (BIO*Asterix®) for industrial applications like paints, coatings, and adhesives. Itaconix focuses on improving the safety, performance, and renewability of consumer goods.

Recent filings

Filing Released Lang Actions
Interim Results
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Unaudited interim results for the 6 month period to 30 June 2017' and contains detailed financial highlights, operational updates, a Chief Executive's statement, and financial performance metrics (revenue, gross profit, loss before taxation). It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2017
2017-09-18 English
Bio-based chelates for the detergents industry
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). The content describes a specific business development: a partnership agreement between Itaconix and AkzoNobel regarding bio-based chelates. This is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific, material corporate event announcement that doesn't fit the other specialized categories like M&A (TAR), Director's Dealing (DIRS), or Capital Change (CAP). Since it is a general regulatory announcement that doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (2876 chars), which aligns with an announcement rather than a full report.
2017-09-05 English
First Bio-based Polymer Application Agreement
Regulatory Filings Classification · 1% confidence The document is very short (3089 characters) and begins with an 'RNS Number' and a date, followed by a headline announcing a finalized agreement between Itaconix and AkzoNobel regarding bio-based polymers. The text concludes with contact information and the statement 'This information is provided by RNS The company news service from the London Stock Exchange'. This structure strongly indicates a general regulatory news service announcement rather than a detailed financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or CAP). Since it is a general regulatory announcement that doesn't fit the other specific categories, the fallback category 'RNS' (Regulatory Filings) is the most appropriate classification.
2017-07-26 English
Block listing Interim Review
Share Issue/Capital Change Classification · 1% confidence The document is titled 'BLOCK LISTING SIX MONTHLY RETURN' and is filed via 'RNS Number : 5073K'. It details the status of unallotted securities under an employee incentive plan over a six-month period (January 10, 2017, to July 9, 2017), including shares issued/allotted during that time. This type of periodic return related to share schemes and listing requirements is a specific regulatory filing. While it relates to capital/shares, it is a formal return submitted to the exchange, not a general announcement of a capital change (SHA) or a transaction in own shares (POS). Given the context of a formal, periodic return submitted via RNS that doesn't fit the other specific categories like 10-K, AR, or ER, the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly provided by the 'RNS' service and is a required periodic disclosure.
2017-07-10 English
Grant of options
Remuneration Information Classification · 1% confidence The document is an official announcement identified by the 'RNS Number' header and the closing statement referencing 'RNS The company news service from the London Stock Exchange'. The content details the 'grant of awards under the Itaconix plc Long Term Incentive Plan ("LTIP") to its executive directors' and includes mandatory disclosure tables regarding transactions by persons discharging managerial responsibilities (PDMRs) under the EU Market Abuse Regulation. This type of mandatory disclosure regarding insider transactions (director dealings) is specifically covered by the 'Director's Dealing' category (DIRS). Although it involves remuneration elements, the primary focus and structure align with insider transaction reporting rather than a full Remuneration Report (DEF 14A).
2017-06-01 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states 'Result of Annual General Meeting' and confirms that 'all resolutions set out in the notice of AGM sent to shareholders were duly passed.' This directly relates to the outcome of the Annual General Meeting. The filing code for AGM Information is AGM-R. Although it is a short announcement, the content is the result itself, not an announcement *about* a report, making AGM-R more specific than RPA or RNS.
2017-05-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.